Good results for B&MThe market seems to have recieved B&M's results positively. The fall in reported profit was expected.
Technically this week could provide a launching pad for it to break to the upside from its weekly 50 ema.
This is not a recommendation. Trade your own plan and make decisions based on your own research.
Stocktrading
TATAMOTORS Support Breach: Bullish Opportunity!🚨 Stock Update: TATAMOTORS 🚨
Date : 16-05-2024
TATAMOTORS breached major support today due to heavy selling pressure and closed at 936.40. I expect the stock to consolidate for a while, which presents a good opportunity to accumulate.
I'm bullish on this stock and plan to buy small quantities below 930 with a stop loss at the next support level (872.10) . My initial target is 1069 .
Stay tuned for important updates and adjustments. Upvote and follow for regular updates! 📈💼
GE HealthCare | GEHCGE Healthcare aka GEHC is a renowned global medical technology, pharmaceutical diagnostics, and digital solutions company that aims to revolutionize healthcare by eliminating limits. With a diverse portfolio of innovative products, services, and solutions, GEHC empowers healthcare professionals to make informed decisions quickly and improve patient care across the entire healthcare continuum. This article delves into the key aspects of GE Healthcare, including its business segments, macro trends driving growth, management incentives, financial performance, competitors, and valuation.
GE Healthcare operates in four business segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. These segments cater to healthcare providers and researchers worldwide, offering a wide range of products and solutions that enhance clinical decision-making and patient outcomes. The company's revenue streams come from the sale of medical devices, consumable products, services, and digital solutions. By focusing on customer-driven innovation, industry-leading service capabilities, and integrated digital solutions, GEHC continually improves the performance, quality, and customer experience of its offerings.
GE Healthcare benefits from several macro trends that are shaping the healthcare industry. The growing adoption of precision health, fueled by advancements in genomics, personalized medicine, and targeted therapies, presents opportunities for GEHC to develop tailored solutions. The global precision medicine market is projected to reach $278.3 billion by 2027, with a CAGR of 10.5%. Additionally, the market for genomic testing is expected to reach $30.9 billion by 2027, growing at a CAGR of 14.7%.
The digitization of healthcare through AI and machine learning enables the analysis of vast amounts of patient data for more accurate diagnoses and treatment decisions. The global healthcare artificial intelligence market is predicted to reach $31.3 billion by 2025, growing at a CAGR of 41.5%. Furthermore, increasing demand for healthcare services driven by demographic trends and improving access to healthcare in emerging markets further support GEHC's growth trajectory. With personalized medicine estimated to have a market value of $3,168.0 billion by 2027, GEHC is well positioned to leverage these trends and provide innovative solutions to meet the evolving needs of the healthcare industry (Sources: Grand View Research, Fortune Business Insights, Allied Market Research, MarketsandMarkets).
GEHC CEO, Peter J. Arduini, has improved incentives in place to drive the company's performance. With an amended offer letter, Arduini's base salary increased to $1,250,000, accompanied by an annual target bonus of 150% of his base salary and an annual long-term incentive grant target of $11,875,000 starting in 2023. These incentives provide a strong motivation for Arduini to lead GEHC's growth and success, enhancing shareholder value.
In 2022, GEHC reported total revenue of $18.34 billion, representing a favorable increase compared to the previous year. Although the profitability declined in the final quarter, the company's operating cash flow and adjusted EBIT margin showed positive trends. GEHC guided organic revenue growth of 5% to 7% for 2023, along with higher adjusted EBIT margin and EPS ranges. The company's commitment to achieving a free cash flow conversion target of 85% or more further reinforces its positive financial outlook.
GEHC faces competition from prominent players in the medical technology industry, including Philips Healthcare, Draeger, Mindray, Masimo, and Baxter. In specific segments, GEHC competes with Siemens Healthineers, Canon, Fujifilm, Carestream, Hologic, and other companies. Despite competition, GEHC's comprehensive product portfolio, customer-focused approach, and commitment to innovation position it well in the market.
GE Healthcare stands out from its competitors in the healthcare sector due to its robust portfolio of cutting-edge products and data-driven solutions. The company's commitment to innovation and advanced technologies enables it to offer unique offerings that address the evolving needs of the industry.
One key area where GEHC excels is precision health. Leveraging advancements in genomics, personalized medicine, and targeted therapies, GEHC develops tailored solutions that provide precise and effective treatments for patients. For example, its innovative imaging technologies, such as magnetic resonance imaging (MRI) and computed tomography (CT), enable high-resolution visualization of anatomical structures, aiding in the accurate diagnosis and monitoring of various medical conditions.
Moreover, GEHC is at the forefront of the digital revolution in healthcare. By harnessing the power of artificial intelligence (AI) and machine learning, GEHC's products analyze vast amounts of patient data to deliver more accurate diagnoses and treatment decisions. For instance, its AI-powered imaging software can detect and analyze anomalies in medical images, helping clinicians detect diseases at an early stage and enhance treatment outcomes. This data-driven approach not only improves patient care but also increases operational efficiency in healthcare facilities.
GEHC's commitment to delivering innovative solutions is further reflected in its diverse product offerings. The company provides a wide range of medical devices, including ultrasound systems, patient monitors, anesthesia machines, and diagnostic imaging equipment. These products are designed to meet the unique needs of healthcare providers and patients, empowering clinicians to make informed decisions and improving patient outcomes.
Based on a valuation analysis using trading multiples of similar companies, GEHC's value is estimated to range from $55 billion to $81 billion. Taking the midpoint of this range, the company's estimated enterprise value (EV) is $64 billion, suggesting a potential stock price of $125. This valuation indicates a significant upside potential of at least 66% within 18 to 24 months from the current price. With its strong market position, growth opportunities, and commitment to advancing healthcare, GEHC presents an attractive investment prospect.
GE Healthcare is a leading global medical technology and digital solutions company with a clear mission to transform healthcare. With its diverse portfolio of products, services, and solutions, GEHC is well-positioned to capitalize on the growing demand for precision health, digitization, and improved access to healthcare. The company's financial performance, management incentives, and competitive landscape further support its growth potential. Considering the estimated valuation, GE Healthcare's stock price has the potential to increase significantly in the next 1.5 to 2 years, offering investors an opportunity for substantial returns.
Watts Water Technologies (WTS) Analysis Industry Leadership:
Watts Water Technologies NYSE:WTS is making significant strides in the plumbing and water filtration industry. CEO Robert J. Pagano Jr. reported record sales, operating earnings, and EPS in Q1, leading to an increased full-year outlook for 2024.
Strategic Acquisitions:
The integration of recent acquisitions—Bradley Corporation, Josam Company, and Enware—is progressing well. These acquisitions are set to drive revenue growth by expanding WTS's market share into new areas. The $303 million Bradley acquisition is particularly impactful, enhancing market share and offering synergistic growth opportunities.
Financial Strength:
WTS's strong balance sheet and robust cash flow support continued strategic investments, shareholder returns, and long-term execution.
Investment Outlook:
Bullish Outlook: We are bullish on WTS above the $184.00-$185.00 range.
Upside Potential: With an upside target set at $315.00-$320.00, investors should monitor the successful integration of acquisitions and sustained financial performance as key growth drivers.
📊🚰 Keep an eye on Watts Water Technologies for promising investment opportunities! #WTS #WaterTechnology 🌊📈
ASIR.N0000📈 Stock ASIR closed at 23.9 on 31/05/2024
🔹 Resistance Level: 25
🔹 200 EMA: 24.8
🔹 Last Friday's candle: Pin Bar
The recent pin bar candle suggests a potential reversal, with the 200 EMA acting as a significant resistance level at 24.8. Keep an eye on this stock as it approaches the 25 resistance level.
Disclaimer: The information and analysis provided in this publication are for educational purposes only and should not be construed as financial advice or recommendations to buy, sell, or hold any securities. The author and TradingView are not responsible for any investment decisions made based on the content presented herein. Always consult a financial professional before making any investment decisions.
SMCI: Strong accumulation. Buy it while you can.Super Micro Computer is neutral on its 1W technical outlook (RSI = 53.442, MACD = 90.250, ADX = 30.355) and the reason is that below the 1W MA50 it is expanding the new Cycle's accumulation phase. Every Cycle experienced this accumulation under the 1W MA50, sometimes shorter others longer. Technically, on a two year basis, every time it crossed under the 1W MA50 and consolidated, the stock was a buy opportunity.
The trigger to buy is given on the S1 level (50.60) of the 1W RSI. The last two Cycles grew by at least +400% from the first low that followed the crossing under the 1W MA50. Consequently we turn long on SMCI, aiming for another +400% rise (TP = 3,300).
## If you like our free content follow our profile to get more daily ideas. ##
## Comments and likes are greatly appreciated. ##
A US Stock Long setup Swing trade👋Hello Traders,
Our 🖥️ AI system detected that there is an H4 or higher timeframe ICT Short setup in US stock : T for Swing trade.
Please refer to the details Stop loss, FVG(Buy Zone),open for take profit.
For more ideas, you are welcome to visit our profile in tradingview.
Have a good day!
Please give this post a like if you like this kind of simple idea, your feedback will bring our signal to next better level, thanks for support!
NIFTY 660+ Points GainAfter a massive week of 660+ points gain, NIFTY has given a SHORT opportunity yesterday.
Days of volatility, guys! BIG money. Everybody is talking about the co-relation of election results.
And why not, market being driven by fundamentals in full power and josh.
A big move is still pending, I dont know if thats gonna happen on Monday 3rd June, 4th June or 5th June. There is a possibility of big gap-ups and gap-downs on these days, specifically.
So, BTST traders, you better watch out and be careful. Risk management is key.
Also, position sizing needs to be watched. You would not want to go in big with a hope to capture big move, only to witness a rude reversal.
NO POSITION IS ALSO A POSITION!
So, be careful, and enjoy the fireworks, gonna start any time now.
S&P 500 (US500):🔴Bearish or bullish...?!🔴By examining the weekly and 4-hour charts, we can determine the price was heavily pushed down after creating the all-time high.
I am not bearish for the long-term on the S&P500, but for now, I think the price can have a bearish reaction to the bearish breaker block and move down at least till the previous week's low, then we should study the price to find out the next move.
💡Wait for the update!
🗓️27/05/2024
🔎 DYOR
💌It is my honor to share your comments with me💌
💻💡 GigaCloud Technology (GCT) Analysis 📊🔍Strategic Acquisitions:
GigaCloud Technology NASDAQ:GCT , a B2B e-commerce solutions provider, recently completed two significant acquisitions: Noble House Home Furnishings' assets for $85 million and Wondersign, a digital signage company, for $10 million. These strategic moves are expected to significantly enhance GigaCloud's revenue and margins.
Leadership Highlights:
CEO Larry Wu emphasized the company's adaptability and strong profitability. Notably, GigaCloud Marketplace's gross merchandise volume surged by 40.8% year-over-year to $684.8 million. Active buyers increased by 9.6%, and spend per buyer rose by 28.5% to $148,793.
Investment Outlook:
Bullish Outlook: We hold a bullish stance on GCT above the $29.00-$30.00 range.
Upside Potential: With a target set at $58.00-$60.00, investors should closely monitor key performance indicators such as growth in merchandise volume and the successful integration of acquisitions.
📈💻 Stay informed about GigaCloud Technology's progress for potential investment opportunities! #GCT #EcommerceSolutions 📊🔍
🍔📈 Shake Shack (SHAK) Analysis 🌍🔍Strong Performance:
Shake Shack NYSE:SHAK , a growing restaurant chain, ended 2023 on a high note with successful sales strategies and margin expansion. CEO Randy Garutti highlighted the opening of 41 new U.S. restaurants and 44 international locations, including in Thailand and the Bahamas. Despite inflationary pressures, same-store sales saw a 2.8% year-over-year increase.
Expansion Potential:
With the Federal Reserve potentially maintaining or lowering interest rates, Shake Shack could see further expansion in 2024. With 518 locations (334 in the U.S.) at the end of 2023, there is significant growth potential. While it may not reach the size of McDonald's, it could approach Five Guys' nearly 1,500 U.S. locations, potentially quadrupling its current count.
Investment Outlook:
Bullish Outlook: We are bullish on SHAK above the $87.00-$88.00 range.
Upside Potential: With an upside target set at $145.00-$150.00, investors should monitor sales growth and expansion efforts as key performance drivers.
📊🍔 Keep a close watch on Shake Shack's growth for promising investment opportunities! #SHAK #RestaurantGrowth 🌍📈
ELI LILLY Preparing for the final buy opportunity.Eli Lilly is on a very steady bullish technical outlook on the 1D timeframe (RSI = 62.145, MACD = 9.380, ADX = 18.580) as it has been trading inside a Channel Up since January 2023. The current bullish vessel within this pattern is a Rising Wedge. As you can see, the two Wedges prior have a last break under the 1D MA50 before rallying to a HH at the top of the Channel Up. The 1D RSI has already crossed over its LH trendline so every pullback that comes in the next 2 weeks, is in our opinion the last buy opportunity. Our target is approximatelly a +45% rise (TP = 1000) which is the rise that all bullish structures prior experienced.
See how our prior idea has worked out:
## If you like our free content follow our profile to get more daily ideas. ##
## Comments and likes are greatly appreciated. ##
Qinetiq breaks out after 4 yearsBreaking out of rectangle patter formed since Feb 20 should mean an upside target of 648.
Good results & defence industry make it more resilient in the face of other factors affecting the economy (e.g. election and recession).
Do your own research and this is not a recommendation to trade in this stock.
Breakout day for QinetiQ - expect pullback to retestWeekly chart: Triangle formed with 2 or more touches to both its upper and lower lines. Early breakout too and could signal a rise to 587. However, if this goes to form, it will retest the upper triangle line at 339 before heading higher.
WARNING: This is not trading advice and just my own technical analysis. Do your own research and trade your own rules.
Nvidia - Earnings, Channel, $1.000!Hello Traders and Investors, today I will take a look at Nvidia .
--------
Explanation of my video analysis:
If you are objectively looking at the stock chart of Nvidia, you can see that Nvidia is currently trading in a solid rising channel formation. But as we are speaking, Nvidia is retesting the upper resistance and considering that we just saw a rally of +700% without any real correction, it is quite likely that we will see at least a short term bearish rejection from here.
--------
Keep your long term vision,
Philip (BasicTrading)
BABA: Set for a Bullish Reversal, Potential Gains Exceed 50%?Hi Realistic Traders, let's delve into the technical analysis of NYSE:BABA !
On the weekly chart, BABA is making some exciting moves! It's broken out of a falling wedge pattern, forming a bullish candlestick with a long wick right on the EMA 34 line. But what really caught our eye? The significant volume spike, more than double the average. Now, why does this matter? Well, it's a clear sign of increased buying interest and strong market conviction behind the price movement. And wait, there's more good news: the MACD indicator is showing a bullish divergence, hinting at a potential reversal. So, what's the forecast? We're looking at a potential upward swing to close the gap near our first target at $117.89. After that, we might see a slight dip to the yellow zone before it continues its rally towards our second target at $165.
It is essential to note that the analysis will no longer hold validity once the target/support area is reached.
Disclaimer: "Please note that this analysis is solely for educational purposes and should not be considered a recommendation to take a long or short position on Alibaba Group Holdings Ltd."
Please support the channel by engaging with the content, using the rocket button, and sharing your opinions in the comments below
BLOCK (SQ): Major Buy Zones Identified Amid Potential Upswing!BLOCK (formerly Square) has experienced a significant sell-off since its all-time high of $290 in July 2021, dropping to a low of $37. This marked the completion of Wave 2 in its price cycle. Currently, we are observing two critical zones:
Must-Buy Zone : Between $33 and $51. Historically, the price has spent minimal but crucial time in this range, indicating strong market movement always follows a dip into this zone.
Okay-Buy Zone : Between $51 and $87. This broader range also saw significant accumulation periods, specifically from May 2018 to March 2020, and again from May 2022 to the present.
BLOCK's price dipped to the Must-Buy Zone recently but quickly reclaimed higher levels, suggesting a potential upswing. Additionally, a clear bullish divergence on the RSI (3-day chart) indicates a possible new momentum phase.
Potential Scenarios:
Retest and Reclaim : On the 12-hour chart, a retest of the high-volume nodes and Points of Control (POC) on the daily and 3-day charts might occur. If BLOCK retests these levels successfully, it could signify a sustained upward movement.
Dip and Buy Opportunity : Should the price fall below these POCs, another dip into the Must-Buy Zone could present an excellent long-term buying opportunity, especially if the RSI indicates oversold conditions aligning with these price points.
Given the bullish divergence on the RSI and historical support levels, there is a strong case for a potential upward movement. However, the risk of a further dip remains, making it crucial to monitor these levels closely for a strategic entry point.